Berlin, Germany
Berlin, Germany

Time filter

Source Type

A method of depositing at least one substance on a target substrate (1) comprises the step of operating at least one droplet dispenser (21) such that droplets (2) including the at least one substance are deposited on the target substrate (1), wherein the target substrate (1) has a substrate surface including spatially delimited receptacle sections (3) being arranged for accommodating the droplets (2), and the at least one droplet dispenser (21) is controlled in dependency on the locations of the receptacle sections (3) such that the droplets (2) are directed onto the receptacle sections (3). Furthermore, a dispenser device (100) for depositing at least one substance on a target substrate (1) is described.


Grant
Agency: European Commission | Branch: FP7 | Program: CP-FP | Phase: KBBE.2010.3.2-04 | Award Amount: 3.89M | Year: 2011

Monitoring the quality of drinking water is of paramount importance for public health. Water is not a commercial product but a heritage that must be protected, defended and treated as such (Water Framework Directive 2000/60/EC). The threat of waterborne diseases in Europe will predictably increase in the future as the human population increases and as a result of globalization and migration from non-EU countries and of climate change. Development of efficient, sensitive, robust, rapid and inexpensive tests to monitor various aspects of water quality represents an essential milestone within the strategy for control and prevention of diseases caused by waterborne pathogens and by algal toxins. Traditional methods for the detection of waterborne pathogens, based on cultivation, biochemical characterisation and microscopic detection are laborious and time-consuming; molecular biological tools have now greatly enhanced our ability to investigate biodiversity by identifying species and to estimate gene flow and distribution of species in time and space. AQUA aims to design and develop a universal microarray chip for the high-throughput detection in water of known and emerging pathogens (bacteria, viruses, protozoa and cyanobacteria) and to assess the water quality monitoring the presence of select bioindicators (i.e. diatoms). A chip able to detect cyanobacterial toxins will also be developed. These innovative molecular tools should be amenable to automation so that they could be deployed on moorings for routine semi-continuous monitoring of water quality. AQUA also aims to identify cyanophages potentially capable of controlling and mitigating the periodical blooming of toxic cyanobacteria in drinking water reservoirs. Overall, these innovative and cost efficient technologies will reduce energy requirements and improve performance of water treatment, and allow rapid management response to new situations brought about by environmental (including climatic) changes.


This report studies sales (consumption) of Nucleic Acid Testing Analyzers in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Abbott Affymetrix Biokit BioMerieux Cepheid Diadexus FUJIREBIO Hologic Li-Cor Biosciences Orchid CellMark Proteome Sciences Qiagen Roche Scienion Sequenom Siemens Beckman Coulter Bio-Rad Johnson & Johnson Thermo Fisher Scientific Agilent Applied Gene Technologies BD Merck Exact Sciences Illumina Kreatech Nanogen/Elitech Novartis Shimadzu Corporation View Full Report With Complete TOC, List Of Figure and Table: http://globalqyresearch.com/united-states-nucleic-acid-testing-analyzers-market-report-2016 Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Nucleic Acid Testing Analyzers in each application, can be divided into Application 1 Application 2 Application 3 United States Nucleic Acid Testing Analyzers Market Report 2016 1 Nucleic Acid Testing Analyzers Overview 1.1 Product Overview and Scope of Nucleic Acid Testing Analyzers 1.2 Classification of Nucleic Acid Testing Analyzers 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Application of Nucleic Acid Testing Analyzers 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 United States Market Size Sales (Value) and Revenue (Volume) of Nucleic Acid Testing Analyzers (2011-2021) 1.4.1 United States Nucleic Acid Testing Analyzers Sales and Growth Rate (2011-2021) 1.4.2 United States Nucleic Acid Testing Analyzers Revenue and Growth Rate (2011-2021) 5 United States Nucleic Acid Testing Analyzers Manufacturers Profiles/Analysis 5.1 Abbott 5.1.1 Company Basic Information, Manufacturing Base and Competitors 5.1.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.1.2.1 Type I 5.1.2.2 Type II 5.1.3 Abbott Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.1.4 Main Business/Business Overview 5.2 Affymetrix 5.2.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.2.2.1 Type I 5.2.2.2 Type II 5.2.3 Affymetrix Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.2.4 Main Business/Business Overview 5.3 Biokit 5.3.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.3.2.1 Type I 5.3.2.2 Type II 5.3.3 Biokit Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.3.4 Main Business/Business Overview 5.4 BioMerieux 5.4.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.4.2.1 Type I 5.4.2.2 Type II 5.4.3 BioMerieux Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.4.4 Main Business/Business Overview 5.5 Cepheid 5.5.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.5.2.1 Type I 5.5.2.2 Type II 5.5.3 Cepheid Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.5.4 Main Business/Business Overview 5.6 Diadexus 5.6.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.6.2.1 Type I 5.6.2.2 Type II 5.6.3 Diadexus Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.6.4 Main Business/Business Overview 5.7 FUJIREBIO 5.7.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.7.2.1 Type I 5.7.2.2 Type II 5.7.3 FUJIREBIO Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.7.4 Main Business/Business Overview 5.8 Hologic 5.8.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.8.2.1 Type I 5.8.2.2 Type II 5.8.3 Hologic Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.8.4 Main Business/Business Overview 5.9 Li-Cor Biosciences 5.9.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.9.2.1 Type I 5.9.2.2 Type II 5.9.3 Li-Cor Biosciences Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.9.4 Main Business/Business Overview 5.10 Orchid CellMark 5.10.2 Nucleic Acid Testing Analyzers Product Type, Application and Specification 5.10.2.1 Type I 5.10.2.2 Type II 5.10.3 Orchid CellMark Nucleic Acid Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.10.4 Main Business/Business Overview 5.11 Proteome Sciences 5.12 Qiagen 5.13 Roche 5.14 Scienion 5.15 Sequenom 5.16 Siemens 5.17 Beckman Coulter 5.18 Bio-Rad 5.19 Johnson & Johnson 5.20 Thermo Fisher Scientific 5.21 Agilent 5.22 Applied Gene Technologies 5.23 BD 5.24 Merck 5.25 Exact Sciences 5.26 Illumina 5.27 Kreatech 5.28 Nanogen/Elitech 5.29 Novartis 5.30 Shimadzu Corporation Global QYResearch ( http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


This report studies sales (consumption) of Tumor Marker Testing Analyzers in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Dako Fujirebio Abbott Beckman Coulter BioMerieux Bio-Rad Olympus America HOLOGIC Qiagen Siemens Roche Thermo Fisher Scientific Johnson & Johnson BD AdnaGen Cepheid Correlogic Systems Diadexus Diagnocure Diasorin Enterix Enzo Biochem Myriad Genetics Panacea Pharmaceuticals Polartechnics Polymedco Radient Pharmaceuticals Scienion Sequenom Targeted Diagnostics & Therapeutics View Full Report With Complete TOC, List Of Figure and Table: http://globalqyresearch.com/united-states-tumor-marker-testing-analyzers-market-report-2016 Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Tumor Marker Testing Analyzers in each application, can be divided into Application 1 Application 2 Application 3 United States Tumor Marker Testing Analyzers Market Report 2016 1 Tumor Marker Testing Analyzers Overview 1.1 Product Overview and Scope of Tumor Marker Testing Analyzers 1.2 Classification of Tumor Marker Testing Analyzers 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Application of Tumor Marker Testing Analyzers 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 United States Market Size Sales (Value) and Revenue (Volume) of Tumor Marker Testing Analyzers (2011-2021) 1.4.1 United States Tumor Marker Testing Analyzers Sales and Growth Rate (2011-2021) 1.4.2 United States Tumor Marker Testing Analyzers Revenue and Growth Rate (2011-2021) 5 United States Tumor Marker Testing Analyzers Manufacturers Profiles/Analysis 5.1 Dako 5.1.1 Company Basic Information, Manufacturing Base and Competitors 5.1.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.1.2.1 Type I 5.1.2.2 Type II 5.1.3 Dako Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.1.4 Main Business/Business Overview 5.2 Fujirebio 5.2.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.2.2.1 Type I 5.2.2.2 Type II 5.2.3 Fujirebio Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.2.4 Main Business/Business Overview 5.3 Abbott 5.3.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.3.2.1 Type I 5.3.2.2 Type II 5.3.3 Abbott Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.3.4 Main Business/Business Overview 5.4 Beckman Coulter 5.4.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.4.2.1 Type I 5.4.2.2 Type II 5.4.3 Beckman Coulter Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.4.4 Main Business/Business Overview 5.5 BioMerieux 5.5.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.5.2.1 Type I 5.5.2.2 Type II 5.5.3 BioMerieux Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.5.4 Main Business/Business Overview 5.6 Bio-Rad 5.6.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.6.2.1 Type I 5.6.2.2 Type II 5.6.3 Bio-Rad Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.6.4 Main Business/Business Overview 5.7 Olympus America 5.7.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.7.2.1 Type I 5.7.2.2 Type II 5.7.3 Olympus America Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.7.4 Main Business/Business Overview 5.8 HOLOGIC 5.8.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.8.2.1 Type I 5.8.2.2 Type II 5.8.3 HOLOGIC Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.8.4 Main Business/Business Overview 5.9 Qiagen 5.9.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.9.2.1 Type I 5.9.2.2 Type II 5.9.3 Qiagen Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.9.4 Main Business/Business Overview 5.10 Siemens 5.10.2 Tumor Marker Testing Analyzers Product Type, Application and Specification 5.10.2.1 Type I 5.10.2.2 Type II 5.10.3 Siemens Tumor Marker Testing Analyzers Sales, Revenue, Price and Gross Margin (2011-2016) 5.10.4 Main Business/Business Overview 5.11 Roche 5.12 Thermo Fisher Scientific 5.13 Johnson & Johnson 5.14 BD 5.15 AdnaGen 5.16 Cepheid 5.17 Correlogic Systems 5.18 Diadexus 5.19 Diagnocure 5.20 Diasorin 5.21 Enterix 5.22 Enzo Biochem 5.23 Myriad Genetics 5.24 Panacea Pharmaceuticals 5.25 Polartechnics 5.26 Polymedco 5.27 Radient Pharmaceuticals 5.28 Scienion 5.29 Sequenom 5.30 Targeted Diagnostics & Therapeutics Global QYResearch ( http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


Patent
Greiner Bio One GmbH and Scienion | Date: 2013-09-11

The present invention relates to a process for the production of a reaction chamber assembly, wherein a flat substrate (10) and bottomless reaction chambers (20) are provided, the substrate (10) is first loaded with a biological agent and then the bottomless reaction chambers (20) are bonded glue-free to the substrate (10), in particular through laser bonding, and liquid-tight reaction chambers, for instance individual wells, individually connected wells, such as strips, or wells in the form of a microtiter plate, are obtained. The present invention further provides a kit comprising a substrate (10) suitable for being loaded with at least one biological agent and at least one bottomless reaction chamber (20), wherein the kit is suitable for glue-free bonding of the bottomless reaction chamber (20) to the substrate (10).


Patent
Greiner Bio One GmbH and Scienion | Date: 2013-09-11

The present invention relates to a process for the production of a reaction chamber assembly, wherein a flat substrate and bottomless reaction chambers are provided, the substrate is first loaded with a biological agent and then the bottomless reaction chambers are bonded glue-free to the substrate, in particular through laser bonding, and liquid-tight reaction chambers, for instance individual wells, individually connected wells, such as strips, or wells in the form of a microtiter plate, are obtained. The present invention further provides a kit comprising a substrate suitable for being loaded with at least one biological agent and at least one bottomless reaction chamber, wherein the kit is suitable for glue-free bonding of the bottomless reaction chamber to the substrate.


Patent
Scienion and Greiner Bio One Gmbh | Date: 2013-03-06

A process for the production of a reaction chamber assembly, wherein a flat substrate and bottomless reaction chambers are provided, the substrate is first loaded with a biological agent and then the bottomless reaction chambers are bonded glue-free to the substrate, in particular through laser bonding, and liquid-tight reaction chambers, for instance individual wells, individually connected wells, such as strips, or wells in the form of a microtiter plate, are obtained. The present invention further provides a kit comprising a substrate suitable for being loaded with at least one biological agent and at least one bottomless reaction chamber, wherein the kit is suitable for glue-free bonding of the bottomless reaction chamber to the substrate.


News Article | February 17, 2017
Site: www.prnewswire.co.uk

Research and Markets has announced the addition of the "Cell Analysis Global Market - Forecast to 2023" report to their offering. The cell analysis market is expected to grow at high single digit CAGR to reach $47,088 million by 2023. The major factor influencing the growth is enhanced precision of cell imaging and analysis systems which in turn reduce time and cost of drug discovery process. In addition, the factors like increasing incidence of cancer, increasing government investments, funds, and grants, availability of reagents and cell analysis instruments are driving the growth of the market. However, the major market restraints include high capital investments and a shortage of skilled labor for the high content screening procedure. The biggest opportunities for this market is the emerging APAC market, high content screening services provided by contract research organizations, automation in cancer research for its early diagnosis and reduction of cost in the cancer treatment. The cell analysis global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the cell analysis global market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K.), Merck KGAA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands) and ThermoFisher Scientific, Inc. (U.S.). In order to offer the products with better software, most of the players in the cell analysis market are collaborating with companies and educational institutions. - 4titude (U.K.) - AB Sciex (U.S.) - Abbott Laboratories, Inc. (U.S.) - Abcam PLC (U.S.) - Abdos (India) - Abnova Corporation (Taiwan) - ACEA Bioscience, Inc (U.S.) - Active Motif (U.S.) - Adnagen (U.S.) - Advanced Cell Diagnostics (U.S.) - Agilent Technologies, Inc. (U.S.) - Alere (U.S.) - Analytik Jena AG (Germany) - Apocell (U.S.) - Applied Microarrays (U.S.) - Ausragen (U.S.) - Auxilab S.L (Spain) - Avantes BV (Netherlands) - Aven Inc (U.S.) - Aviva Bioscience (U.S.) - Becton Dickinson and Company (U.S.) - BGI (China) - Bibby Scientific Limited (U.K.) - Bio Care Medical LLC (U.S.) - BioDot Inc. (U.S.) - Biofluidica (U.S.) - Biologics (China) - BioMerieux SA (Germany) - Bio-Rad Laboratories (U.S.) - Bioron (France) - Biosearch Technologies (U.S.) - BioView (Israel) - BMS microscopes (Netherlands) - Bruker (U.S.) - Canopus Bioscience (U.S.) - Capp ApS (Denmark) - Carl Zeiss AG (Germany) - Cell Signaling Technology, Inc. (U.S.) - Cell-Vu (U.S.) - Cherry Biotech (France) - Cisbio Bioassays (France) - Clearbridge BioMedics (Singapore) - Corning Inc (U.S.) - Creatv Microtech inc (U.S.) - Cyflogic (Finland) - Cynvenio Biosystems (U.S.) - Cytognos S.L. (Spain) - DaAn Gene (China) - Danaher Corporation (U.S.) - Danish Micro Engineering (Denmark) - Diagenode (Netherlands) - DiscoveRx (U.S.) - Domel (Slovenia) - Dragon Laboratory Instruments Ltd (China) - eBioscience, Inc., (U.S.) - Eppendorf (Germany) - Etaluma, Inc (U.S.) - Eurofins Scientific (Luxembourg) - EXIQON (Denmark) - FEI Company (U.S.) - Fluidgm Corporation (U.S.) - Fluxion Biosciences (U.S.) - GE Healthcare (U.K.) - Genedata AG (Switzerland) - Genemed Biotechnologies Inc (U.S.) - General Biologicals (Taiwan) - Gyros AB (Sweden) - Handyem (Canada) - Hausser Scientific (U.S.) - Herolab GmbH (Germany) - Hettich lab technology (Germany) - Hoffmann-La Roche (Switzerland) - HORIBA, Ltd. (Japan) - Illumina (U.S.) - Immunodiagnostics systems (France) - Jasco (U.S.) - Jena Biosciences (Germany) - JEOL, Ltd. (Japan) - Jasco Analytical Instruments (U.S.) - Kapa Biosystems (U.S.) - Keyence Corporation (U.S.) - Kyratec (Australia) - Labcon (U.S.) - Labnet International, Inc (U.S.) - Lubio Science (Switzerland) - Luminex Corporation (U.S.) - LW Scientific (U.S.) - Macrogen Inc (South Korea) - Medical Econet (Austria) - Meijo techno (U.K.) - Merck KGaA (Germany) - Mettler-Toledo, Inc. (U.S.) - Micro-shot Technology Ltd (China) - Miltenyil Biotec (Germany) - Nanostring Technologies (U.S.) - New England Biolabs (U.S.) - Nikon Corporation (Japan) - Olympus Corporation (Japan) - Optika SRL., (Italy) - Ortho Clinical Diagnostics (U.S.) - Ortoalresa (Spain) - Oxford Nanopore Technologies, Ltd. (U.K.) - Pacific Biosciences (U.S.) - Panagene (South Korea) - Park Systems (Korea) - PerkinElmer Inc (U.S.) - Pheonix (U.S.) - PicoQuant GmbH (Germany) - Promega Corporation (U.S.) - Qiagen N.V. (Netherlands) - Quest Diagnostics (U.S.) - R&D Systems (U.S.) - Rain Dance Technologies (U.S.) - Rheonix (U.S.) - Rigaku Corporation (Japan) - RR Mechatronics (Netherlands) - Sacace Biotechnologies (Italy) - Sanyo (Japan) - Scienion (Germany) - Scientific Specialities Inc (U.S.) - Seegene (South Korea) - Seimens Healthcare (Germany) - Separation Technology, Inc (U.S.) - Shimadzu Scientific Instruments (Japan) - Sigma Laborzentrifugen GmbH (Germany) - Sohn GmbH (Germany) - Sony Biotechnology (U.S.) - Sprenson Bioscience (U.S.) - Stemcell Technologies (Canada) - Sysmex (Japan) - Tecan (Switzerland) - The Western Electric & Scientific Works (India) - ThermoFisher Scientific Inc (U.S.) - Thorlabs (U.S.) - Toyo Gosei Co., Ltd (Japan) - TrimGen Genetic Diagnostics (U.S.) - Vision Scientific Co Ltd (Korea) - Visitron Systems Gmbh (Germany) - Waters Corporation (U.S.) - Yokogawa Electric Corporation (Japan) - Zymo Research (U.S.) For more information about this report visit http://www.researchandmarkets.com/research/ngm5k6/cell_analysis About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Patent
Scienion | Date: 2012-08-22

The invention relates to a microdispenser (1) for dispensing a liquid sample in a dispensing device, with a sample container (2) for receiving the liquid sample, and with a nozzle (7) for dispensing the sample located in the sample container (2). The microdispenser (1) with the filled sample container (2) can in this case be stored independently of and fluidically separately from the dispensing device, without the sample escaping from the sample container (2) during storage.


Loading Scienion collaborators
Loading Scienion collaborators